CollPlant Biotechnologies Ltd. (ADR)
General ticker "CLGN" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $21.8M (TTM average)
CollPlant Biotechnologies Ltd. (ADR) does not follow the US Stock Market performance with the rate: -20.4%.
Estimated limits based on current volatility of 4.8%: low 0.40$, high 0.44$
Factors to consider:
- Total employees count: 39 as of 2017
- Current price 62.9% below estimated low
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [1.15$, 3.26$]
- 2026-12-31 to 2027-12-31 estimated range: [1.33$, 3.59$]
Financial Metrics affecting the CLGN estimates:
- Positive: with PPE of -1.1 at the end of fiscal year the price was neutral
- Negative: Operating cash flow per share per price, % of -52.94 <= 0.02
- Negative: negative Operating income
- Positive: Investing cash flow per share per price, % of -0.15 > -0.63
- Positive: 42.58 < Shareholder equity ratio, % of 56.38 <= 64.15
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Positive: Interest expense per share per price, % of 0.08 <= 0.73
- Negative: negative Net income
- Positive: Inventory ratio change, % of -26.61 <= -0.74
Short-term CLGN quotes
Long-term CLGN plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $10.96MM | $0.52MM | $2.37MM |
| Operating Expenses | $18.47MM | $17.77MM | $13.85MM |
| Operating Income | $-7.51MM | $-17.25MM | $-11.48MM |
| Non-Operating Income | $0.49MM | $0.64MM | $-0.01MM |
| Interest Expense | $0.01MM | $0.02MM | $0.01MM |
| R&D Expense | $10.48MM | $10.52MM | $8.19MM |
| Income(Loss) | $-7.02MM | $-16.61MM | $-11.49MM |
| Profit(Loss)* | $-7.02MM | $-16.61MM | $-11.49MM |
| Stockholders Equity | $28.34MM | $13.46MM | $6.08MM |
| Inventory | $0.71MM | $0.44MM | $0.57MM |
| Assets | $34.13MM | $18.71MM | $10.79MM |
| Operating Cash Flow | $-2.76MM | $-14.09MM | $-9.42MM |
| Capital expenditure | $0.95MM | $0.48MM | $0.03MM |
| Investing Cash Flow | $-1.16MM | $-0.54MM | $-0.03MM |
| Financing Cash Flow | $1.11MM | $0.01MM | $3.10MM |
| Earnings Per Share** | $-0.62 | $-1.45 | $-0.94 |
| Ordinary share to ADR | 1.00x | 1.00x | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.